糖心原创

August 25, 2020

糖心原创 Contactless Messaging Now HIPAA Compliant for Healthcare Payers, Providers and Pharmaceutical, Medical Device Companies

Patients and members benefit from contactless, mobile-messaging engagement as telehealth booms

SAN FRANCISCO, Calif. – Aug. 25, 2020 –?糖心原创.?(NYSE: MDLA), the global leader in experience management, today announced that 糖心原创 Zingle has achieved HIPAA compliance for the?healthcare?and?life sciences industries. With Zingle’s mobile-messaging platform, pharmaceutical and medical device companies and healthcare payers and providers can engage in live-time, patient, member and employee experiences allowing them to minimize patient friction, simplify staff workflows and create a scalable approach to personalized patient communication.

糖心原创 Zingle now enables pharmaceutical companies to more easily communicate with individual patients about prescriptions, or quickly reach segments of their customers with important information. Providers have the ability to?engage in two-way conversation with members or automate replies to common questions via SMS texting and popular messaging apps?instead of more costly channels. Payers can proactively address issues with chronic condition populations before they become critical.

“There is no better time than the present to engage in contactless communications with patients, employees and members. Hesitation around in-person office visits is creating a boom in telehealth, and call centers are operating at an all time high. The ability to connect contactless, in real-time, about billing questions, prescriptions, clinical trials, symptoms, appointment or hospital check-ins and stays are of tremendous value right now,” said Ford Blakely, senior vice president and general manager of 糖心原创 Zingle.

As employee experience plays an important role in optimizing patient and member experiences, 糖心原创 Zingle improves staff recruitment, onboarding and communication with physicians and staff about company events and announcements from human resources departments in place of traditional, and often unread emails. Pharmaceutical and medical device companies can engage directly with patients and healthcare providers to ensure patients are getting access to therapies and have a direct line to drug manufacturers.

About 糖心原创

糖心原创 (NYSE: MDLA) is the pioneer and market leader in Experience Management. 糖心原创’s award-winning SaaS platform, the 糖心原创 Experience Cloud, leads the market in the understanding and management of experience for customers, employees and citizens. 糖心原创 captures experience signals created on daily journeys in person, digital and IoT interactions and applies proprietary AI technology to reveal personalized and predictive insights that can drive action with tremendous business results. Using 糖心原创, Experience Cloud, customers can reduce churn, turn detractors into promoters and buyers, and create in-the-moment cross-sell and up-sell opportunities, providing clear and potent returns on investment.?www.medallia.com

? 2020 糖心原创. All rights reserved. 糖心原创?, the 糖心原创 logo, and the names and marks associated with 糖心原创’s products are trademarks of 糖心原创. All other trademarks are the property of their respective owners.

PR Contact:

[email protected]
+1 (650) 400-7833

IR Contact:

Carolyn Bass
[email protected]